This Company Is Doubling Down on AI. Is the Stock a Buy? [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
There are other reasons to buy the stock. 10 stocks we like better than Eli Lilly › Investors looking to capitalize on the growing artificial intelligence (AI) industry are mostly turning to the tech sector, which is home to some of the best AI stocks on the market. However, companies in other industries are also using AI in ways that could improve their businesses and make them more attractive investments. Consider Eli Lilly (NYSE: LLY) , the world's most valuable healthcare company, which recently announced an AI-related initiative. Does the company's work in this field make the stock a buy? On Jan. 12, Eli Lilly announced that it would partner with Nvidia (NASDAQ: NVDA) to build an innovation lab in the San Francisco Bay area. The lab will bring together some of Eli Lilly's experienced researchers and Nvidia's engineers to collaborate on building AI models to accelerate drug discovery. The two companies will invest up to $1 billion over five years in this initiative. Why
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid' launch [CNBC]CNBC
- Eli Lilly: Exceptional 2025, But Rising Headwinds Loom In 2026 [Seeking Alpha]Seeking Alpha
- Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead [Yahoo! Finance]Yahoo! Finance
- JPM26: Eli Lilly's obesity drugs target commercial and governmental access [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Jefferies Financial Group Inc. from $976.00 to $1,300.00. They now have a "buy" rating on the stock.MarketBeat
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website